After targeted agents, a novel bispecific in EGFR-mutant lung cancer improves PFS.

Published Date: 03 Jun 2024

FDA approval could be hampered by a trial conducted in China, though.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests

2.

Six breast texture patterns linked to higher risk of invasive cancer

3.

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

4.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

5.

Firefighters who eat better can combat cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot